OYST · Categories · Form 4

OYST - SEC Form 4 insider transactions

Oyster Point Pharma Inc. (OYST) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for OYST

• 1250d
  SEC Form 4 filed by Invopps Gp Iv, L.L.C.

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1251d
  SEC Form 4 filed by Versant Venture Capital Vi, L.P.

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1251d
  SEC Form 4: Behbahani Ali returned 13,639 shares to the company, closing all direct ownership in the company (for tax liability)

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1251d
  SEC Form 4 filed by New Enterprise Associates 14, L.P.

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1251d
  SEC Form 4: Weisner Aimee S returned 36,764 shares to the company, closing all direct ownership in the company (for tax liability)

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1251d
  SEC Form 4: Tsai Benjamin returned 3,573 shares to the company, closing all direct ownership in the company (withholding obligation)

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1251d
  SEC Form 4: Santel Donald J returned 8,198 shares to the company, closing all direct ownership in the company to cover withholding tax

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1251d
  SEC Form 4: Ozawa Clare returned 14,637 shares to the company, closing all direct ownership in the company (withholding tax)

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1251d
  SEC Form 4: Nau Jeffrey covered exercise/tax liability with 2,607 shares and returned 48,975 shares to the company, closing all direct ownership in the company to satisfy withholding tax

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1251d
  SEC Form 4: Murray Mark Anthony returned 122,086 shares to the company, closing all direct ownership in the company to satisfy withholding tax

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1251d
  SEC Form 4: Lochner Daniel covered exercise/tax liability with 938 shares and returned 20,236 shares to the company, closing all direct ownership in the company (tax liability)

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1251d
  SEC Form 4: Eliades George Christopher returned 28,624 shares to the company, closing all direct ownership in the company (tax liability)

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1251d
  SEC Form 4: Atieh Michael G returned 8,671 shares to the company, closing all direct ownership in the company (withholding obligation)

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1280d
  SEC Form 4: Nau Jeffrey covered exercise/tax liability with 8,938 shares, decreasing direct ownership by 6% to 148,660 units to cover withholding tax (Amendment)

  4/A - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1280d
  SEC Form 4: Lochner Daniel covered exercise/tax liability with 3,258 shares, decreasing direct ownership by 4% to 74,463 units (for tax liability)

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1281d
  SEC Form 4: Nau Jeffrey covered exercise/tax liability with 6,217 shares, decreasing direct ownership by 4% to 151,381 units to satisfy withholding obligation

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1431d
  SEC Form 4 filed by Lochner Daniel

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1431d
  SEC Form 4 filed by Nau Jeffrey

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1461d
  SEC Form 4: Behbahani Ali was granted 3,573 shares, increasing direct ownership by 35% to 13,639 units

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1461d
  SEC Form 4: Ozawa Clare was granted 3,573 shares, increasing direct ownership by 32% to 14,637 units

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1461d
  SEC Form 4: Eliades George Christopher was granted 3,573 shares, increasing direct ownership by 14% to 28,624 units

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1461d
  SEC Form 4: Weisner Aimee S was granted 3,573 shares, increasing direct ownership by 11% to 36,764 units

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1461d
  SEC Form 4: Tsai Benjamin was granted 3,573 shares, increasing direct ownership by 35% to 13,639 units

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1461d
  SEC Form 4: Murray Mark Anthony was granted 3,573 shares, increasing direct ownership by 3% to 122,086 units

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1461d
  SEC Form 4: Atieh Michael G was granted 3,573 shares, increasing direct ownership by 15% to 26,734 units

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1461d
  SEC Form 4: Santel Donald J was granted 3,573 shares, increasing direct ownership by 35% to 13,687 units

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1609d
  SEC Form 4: Snisarenko John was granted 12,100 shares, increasing direct ownership by 66% to 30,322 units

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1609d
  SEC Form 4: Nau Jeffrey was granted 46,700 shares, increasing direct ownership by 42% to 157,598 units

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1609d
  SEC Form 4: Lochner Daniel was granted 19,500 shares, increasing direct ownership by 33% to 77,721 units

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1613d
  SEC Form 4: Link William J Phd acquired 6,839 shares

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1613d
  SEC Form 4: Versant Venture Capital Vi, L.P. disposed of 253,030 shares and acquired 51,556 shares

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1613d
  SEC Form 4: Ozawa Clare disposed of 253,030 shares as part of a pre-agreed trading plan and acquired 51,676 shares as part of a pre-agreed trading plan, increasing direct ownership by 1% to 11,064 units

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1628d
  SEC Form 4: Link William J Phd acquired 6,838 shares

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1628d
  SEC Form 4: Ozawa Clare disposed of 253,030 shares as part of a pre-agreed trading plan and acquired 51,676 shares as part of a pre-agreed trading plan, increasing direct ownership by 1% to 10,944 units

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1628d
  SEC Form 4: Versant Venture Capital Vi, L.P. disposed of 253,030 shares and acquired 51,556 shares

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1679d
  SEC Form 4: Lochner Daniel exercised 8,590 shares at a strike of $11.51, increasing direct ownership by 17% to 58,221 units

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1690d
  SEC Form 4: Nau Jeffrey exercised 50,000 shares at a strike of $1.02, increasing direct ownership by 82% to 110,898 units

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1692d
  SEC Form 4: Versant Venture Capital Vi, L.P. sold $8,160,736 worth of shares (550,000 units at $14.84)

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1692d
  SEC Form 4: Link William J Phd sold $8,160,736 worth of shares (550,000 units at $14.84) as part of a pre-agreed trading plan

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1692d
  SEC Form 4: Ozawa Clare sold $8,160,736 worth of shares (550,000 units at $14.84) as part of a pre-agreed trading plan

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1718d
  SEC Form 4 filed by Snisarenko John

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1735d
  SEC Form 4: Lochner Daniel exercised 7,500 units of Common Stock at a strike of $11.51, increasing direct ownership by 18% to 49,631 units

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1741d
  SEC Form 4: Nau Jeffrey exercised 10,000 units of Common Stock at a strike of $1.02, increasing direct ownership by 20% to 60,898 units

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1743d
  SEC Form 4 filed by Lochner Daniel

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1770d
  SEC Form 4: Santel Donald J was granted 10,114 units of Common Stock

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1775d
  SEC Form 4: Lochner Daniel exercised 7,500 units of Common Stock at a strike of $11.51, increasing direct ownership by 22% to 42,131 units

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1825d
  SEC Form 4 filed by Oyster Point Pharma, Inc.

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1825d
  SEC Form 4 filed by Oyster Point Pharma, Inc.

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1825d
  SEC Form 4: Behbahani Ali was granted 3,466 units of Common Stock, increasing direct ownership by 53% to 10,066 units

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1825d
  SEC Form 4 filed by Oyster Point Pharma, Inc.

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1825d
  SEC Form 4: Tsai Benjamin was granted 3,466 units of Common Stock, increasing direct ownership by 53% to 10,066 units

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1825d
  SEC Form 4: Murray Mark Anthony was granted 3,466 units of Common Stock, increasing direct ownership by 3% to 118,513 units

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1825d
  SEC Form 4 filed by Oyster Point Pharma, Inc.

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1825d
  SEC Form 4 filed by Oyster Point Pharma, Inc.

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1851d
  SEC Form 4 filed by Versant Venture Capital VI, L.P.

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1851d
  SEC Form 4: Ozawa Clare increased direct ownership by 3% to 7,358 units

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1851d
  SEC Form 4 filed by LINK WILLIAM J PHD

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1890d
  SEC Form 4: Christopher George Eliades was granted 21,585 units of Common Stock

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1893d
  SEC Form 4: Jeffrey Nau exercised 10,000 units of Common Stock at a strike of $1.02, increasing direct ownership by 24% to 50,898 units

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)
• 1896d
  SEC Form 4 filed by Phd J William Link

  4 - Oyster Point Pharma, Inc. (0001720725) (Issuer)

Other OYST categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends